BIM
ASPX

BlackRock Investment Management’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

BlackRock Investment Management’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-30,307
Closed -$3.04M – 4306
2015
Q1 		$3.04M Buy
30,307
+3,337
+12% +$222K ﹤0.01% 1736
2014
Q4 		$1.42M Sell
26,970
-105
-0.4% -$3.08K ﹤0.01% 2308
2014
Q3 		$695K Buy
27,075
+3,392
+14% +$72.2K ﹤0.01% 2775
2014
Q2 		$527K Buy
23,683
+652
+3% +$14.3K ﹤0.01% 3017
2014
Q1 		$708K Buy
+23,031
New +$619K ﹤0.01% 2755

BlackRock Investment Management's ASPX Position: Q2 2015 in Review

BlackRock Investment Management sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 30,307 shares — an estimated $3.04M sold.

BlackRock Investment Management first reported a position in ASPX in Q1 2014 and held it in 5 quarters. The position peaked at $3.04M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • BlackRock Investment Management reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • BlackRock Investment Management sold 30,307 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $3.04M.
  • BlackRock Investment Management first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 5 quarters.
  • BlackRock Investment Management's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $3.04M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on BlackRock Investment Management's 13F filing for Q2 2015, filed 7 Aug 2015.